Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells.
Abstract
T cells are prominent components of both early and late atherosclerotic lesions and the role of Th1/Th2 cells subsets in the evolution and rupture of the plaque is currently under investigation. Statins, which are inhibitors of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase, exert actions beyond that of simply lowering cholesterol levels, and some effects on immune function have been reported. We studied in vitro the effects of fluvastatin on Th1/Th2 cytokine release in relation to caspase-1 activation, in human peripheral-blood mononuclear cells (PBMC) stimulated or not with Mycobacterium tuberculosis. Fluvastatin treatment resulted in the activation of caspase-1 and in a small secretion of interleukin (IL)-1beta, IL-18, and IFNgamma (Th1). In the presence of bacteria, the release of these cytokines was highly increased by the statin in a synergistic way. By contrast, production of IL-12, IL-10 and IL-4 were unaffected by the statin. Not only did mevalonate abolish the effects of the statin but it also prevented the caspase-1 activation induced by the bacteria, suggesting the involvement of isoprenoids in the response to M. tuberculosis. It is proposed that inhibition of HMG-CoA reductase may be immunoprotective by enhancing the Th1 response, which has therapeutical potential not only in atherosclerosis but also in infectious diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fluvastatin enhances the Th1 protective response to Mycobacterium tuberculosis infection in human peripheral blood mononuclear cells via increased Caspase I activity.
“in a study investigating the in vitro role of fluvastatin in Mycobacterium tuberculosis infection in human peripheral blood mononuclear cells, fluvastatin was found to enhance the Th1 protective response to the infection (Montero et al., 2000). The proposed mechanism for this effect was an increased activity of Caspase I.”
From Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice (2015) · cites this paper as Montero et al., 2000
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618 · see citing works
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N., Bull, H., Calaycay, J., Chapman, K., Howard, A., Kostura, M., Miller, D. K., Molineaux, S., Weidner, J., Auniņš, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,725 · see citing works
Atherosclerosis: Basic Mechanisms
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,726 · see citing works
Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production
Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter, A. B., Quintal, L. J., Sekut, L., Talanian, R. V., Paskind, M. P., et al. (1997) · Nature · doi:10.1038/386619a0 · Cited by 1,204 · see citing works
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190 · see citing works
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,175 · see citing works
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme
Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., et al. (1997) · Science · doi:10.1126/science.275.5297.206 · Cited by 1,159 · see citing works
Frostegård, J., Ulfgren, A., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002 · see citing works
New Concepts about the Mast Cell
Flier, J. S., Underhill, L. H., & Galli, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280408 · Cited by 991 · see citing works
Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S., & Pickup, D. J. (1992) · Cell · doi:10.1016/0092-8674(92)90223-y · Cited by 977 · see citing works
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
Enari, M., Talanian, R. V., Wrong, W. W., & Nagata, S. (1996) · Nature · doi:10.1038/380723a0 · Cited by 958 · see citing works
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S. K. S., Pablo, A. M., Jiang, X., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 863 · see citing works
Kovanen, P. T., Kaartinen, M., & Paavonen, T. (1995) · Circulation · doi:10.1161/01.cir.92.5.1084 · Cited by 615 · see citing works
Amento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609 · see citing works
Pahan, K., Sheikh, F. G., Namboodiri, A. M., & Singh, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119812 · Cited by 571 · see citing works
Regulation of interferon-γ production by IL-12 and IL-18
Okamura, H., Kashiwamura, S., Tsutsui, H., Yoshimoto, T., & Nakanishi, K. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80163-5 · Cited by 523 · see citing works
Kohno, K., Kataoka, J., Ohtsuki, T., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1541 · Cited by 521 · see citing works
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427 · see citing works
Interferon-γ: Biology and Role in Pathogenesis
Billiau, A. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60428-9 · Cited by 417 · see citing works
Zhou, X., Paulsson, G. B., Stemme, S., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1216 · Cited by 414 · see citing works
Weber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 411 · see citing works
Is atherosclerosis an immunologically mediated disease?
Wick, G., Schett, G. A., Amberger, A., Kleindienst, R., & Xu, Q. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80067-0 · Cited by 398 · see citing works
Puren, A. J., Fantuzzi, G., & Dinarello, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2256 · Cited by 379 · see citing works
Vastatins Inhibit Tissue Factor in Cultured Human Macrophages
Colli, S., Eligini, S., Lalli, M., Camera, M., Paoletti, R., & Tremoli, E. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.2.265 · Cited by 348 · see citing works
Laine, P., Kaartinen, M., Penttilä, A., Panula, P., Paavonen, T., & Kovanen, P. T. (1999) · Circulation · doi:10.1161/01.cir.99.3.361 · Cited by 343 · see citing works
Howard, A. D., Kostura, M. J., Thornberry, N. A., DING, G. J.-F., Limjuco, G. A., Weidner, J. R., Salley, J. P., Hogquist, K. A., Chaplin, D., & Mumford, R. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.2964 · Cited by 323 · see citing works
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
Lee, T., Yen, H.-C., Pan, C., & Chau, L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 311 · see citing works
Expression of Interleukin-10 in Advanced Human Atherosclerotic Plaques
Mallat, Z., Heymes, C., Ohan, J., Faggin, E., Lesèche, G., & Tedgui, A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.611 · Cited by 265 · see citing works
Geng, Y., & Hansson, G. K. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115718 · Cited by 265 · see citing works
Bohn, E., Sing, A., Zumbihl, R., Bielfeldt, C., Okamura, H., Kurimoto, M., Heesemann, J., & Autenrieth, I. B. (1998) · PubMed · Cited by 230 · see citing works
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
Marcelli, M., Cunningham, G. R., Haidacher, S. J., Padayatty, S. J., Sturgis, L., Kagan, C., & Denner, L. A. (1998) · PubMed · Cited by 210 · see citing works
[43] Interleukin-1β converting enzyme
Thornberry, N. A. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)44045-x · Cited by 204 · see citing works
Bohn, E., Sing, A., Zumbihl, R., Bielfeldt, C., Okamura, H., Kurimoto, M., Heesemann, J., & Autenrieth, I. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.299 · Cited by 204 · see citing works
THE PATHOGENESIS OF TUBERCULOSIS
Rook, G. A. W., & Hernández‐Pando, R. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.micro.50.1.259 · Cited by 175 · see citing works
Cell-mediated immunity in atherosclerosis
Hansson, G. K. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00009 · Cited by 171 · see citing works
Schumann, R. R., Belka, C., Reuter, D., Lamping, N., Kirschning, C. J., Weber, J. R., & Pfeil, D. (1998) · Blood · doi:10.1182/blood.v91.2.577 · Cited by 165 · see citing works
Hilbi, H., Chen, Y., Thirumalai, K., et al. (1997) · Infection and Immunity · doi:10.1128/iai.65.12.5165-5170.1997 · Cited by 164 · see citing works
Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?
Massy, Z. A., Keane, W. F., & Kasiske, B. L. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90217-2 · Cited by 161 · see citing works
Kishikawa, H., Shimokama, T., & Watanabe, T. (1993) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01606532 · Cited by 159 · see citing works
T lymphocytes inhibit the vascular response to injury.
Hansson, G. K., Holm, J., Holm, S., et al. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10530 · Cited by 152 · see citing works
Chakrabarti, R., & Engleman, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98884-8 · Cited by 145 · see citing works
IL-18 Promotes Type 1 Cytokine Production from NK Cells and T Cells in Human Intracellular Infection
García, V., Uyemura, K., Sieling, P. A., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6114 · Cited by 140 · see citing works
Shalhoub, V., Faust, J., Boyle, W. J., Dunstan, C. R., Kelley, M., Kaufman, S., Scully, S. A., Van, G. Y., & Lacey, D. L. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990201)72:2 · Cited by 123 · see citing works
Hwang, C., Martin, D. J., Goodman, J. S., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00114-9 · Cited by 121 · see citing works
Makkonen, N., Salminen, A., Rogers, M. J., et al. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(98)00065-7 · Cited by 113 · see citing works
Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages
Ladel, C. H., Szalay, G., Riedel, D., et al. (1997) · Infection and Immunity · doi:10.1128/iai.65.5.1936-1938.1997 · Cited by 96 · see citing works
Chizzolini, C., Chicheportiche, R., Burger, D., & Dayer, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270125 · Cited by 89 · see citing works
Coxon, F. P., Benford, H. L., Russell, R. G. G., et al. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13063-5 · Cited by 89 · see citing works
Chin, J. E., & Kostura, M. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5574 · Cited by 83 · see citing works
Cytokine Modulation of LDL Oxidation by Activated Human Monocytes
Folcik, V. A., Aamir, R., & Cathcart, M. K. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.1954 · Cited by 79 · see citing works
Mönkkönen, J., Similä, J., & Rogers, M. J. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)01178-8 · Cited by 79 · see citing works
Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis
George, S. J. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00005 · Cited by 76 · see citing works
Barsig, J., & Kaufmann, S. H. E. (1997) · Infection and Immunity · doi:10.1128/iai.65.10.4075-4081.1997 · Cited by 73 · see citing works
Xu, Q., Kleindienst, R., Schett, G. A., et al. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05800-5 · Cited by 69 · see citing works
Sekine, C., Yagita∥, H., Kobata, T., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1610 · Cited by 63 · see citing works
Terkeltaub, R. A., Solan, J. L., Barry, M. E., Santoro, D. A., & Bokoch, G. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.6.749 · Cited by 55 · see citing works
Vitale, M., Matola, T. D., Rossi, G., et al. (1999) · Endocrinology · doi:10.1210/endo.140.2.6494 · Cited by 45 · see citing works
Interleukin‐1β converting enzyme
Reiter, L. A., & Martin, J. J. (1993) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1993.tb00467.x · Cited by 43 · see citing works
Transformation-specific secreted phosphoproteins
Senger, D. R., Wirth, D. F., & Hynes, R. O. (1980) · Nature · doi:10.1038/286619a0 · Cited by 40 · see citing works
The Role of Mast Cells in Atherosclerosis
Metzler, B., & Xu, Q. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237636 · Cited by 39 · see citing works
Miossec, C., Decoen, M., Durand, L., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260512 · Cited by 33 · see citing works
Human Cellular Immune Responses to Mycobacterium tuberculosis
Barnes, P. F., & Modlin, R. L. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80166-2_9 · Cited by 28 · see citing works
Carrero, P., Ortega, H., Martı́nez-Botas, J., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00635-7 · Cited by 24 · see citing works
Self-citationEffects of activation on lipid and lipoprotein metabolism in murine macrophages.
Kraemer, F. B., Tavangar, K., Gandjei, R. K., Kirlew, K., & Behr, S. R. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.1.8 · Cited by 23 · see citing works
Rossen, R. D. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00325-2 · Cited by 22 · see citing works
New developments in the use of cytokines for cancer therapy.
Maini, A., Morse, P., Cy, W., et al. (1998) · PubMed · Cited by 11 · see citing works
Vitale, M. (1999) · Endocrinology · doi:10.1210/en.140.2.698 · Cited by 10 · see citing works
Effect of HMG CoA reductase inhibition on TGF-beta 1 mRNA expression in diabetic rat glomeruli.
Dc, H., Jh, K., Mk, C., et al. (1995) · PubMed · Cited by 9 · see citing works
Down-modulation of mycobacterial-induced IL-1β production in human mononuclear cells by IL-4
Méndez‐Samperio, P., Hernández-Garay, M., Badillo-Flores, A., et al. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.06695.x · Cited by 7 · see citing works
Atherosclerosis and the Immune System
Niculescu, F. I., & Rus, H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.315 · Cited by 5 · see citing works
[Kinetics of vascular wall cells and atherogenesis].
Nagornev, V. A. (1998) · PubMed · Cited by 1 · see citing works
Seely, S. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00246-0 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Targeting inflammation in the treatment of type 2 diabetes: time to start
Donath, M. Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4275 · Cited by 690 · see citing works
Koushki, K., Shahbaz, S. K., Mashayekhi, K., Sadeghi, M., Zayeri, Z. D., Taba, M. Y., Banach, M., Al-Rasadi, K., Johnston, T. P., & Sahebkar, A. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08791-9 · Cited by 382 · see citing works
The role of interleukin-18 in the metabolic syndrome
Trøseid, M., Seljeflot, I., & Arnesen, H. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-11 · Cited by 155 · see citing works
Sun, H., & Singh, N. (2009) · Clinical Infectious Diseases · doi:10.1086/597039 · Cited by 65 · see citing works
Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice
Rahal, E. A., Constantin, W. N., Zeidan, N., & Abdelnoor, A. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01474 · Cited by 14 · see citing works
Dominguez, J., Mendes, A. I., Pacheco, A. R., Peixoto, M. J., Pedrosa, J., & Fraga, A. G. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1266261 · Cited by 4 · see citing works
- Authors
- Montero, M. T., Hernández, O., Suárez, Y., Matilla, J., Ferruelo, A. J., Martı́nez-Botas, J., Gómez-Coronado, D., & Lasunción, M. A.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Universidad de Alcalá (ES)
- Corresponding author
- Lasunción, Miguel A
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 153
- Issue
- 2
- Pages
- 303-313
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2084961971
- Cited by
- 97
- References
- 73
- Citations by year
- 2026: 2 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 6 · 2019: 6 · 2018: 3 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 2 · 2012: 3
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- HMG-CoA reductase inhibition, statins, fluvastatin, caspase-1 activation, Th1 cytokines, Th1/Th2 balance, peripheral blood mononuclear cells, Mycobacterium tuberculosis, IL-1β, IL-18, interferon-gamma, mevalonate, terpenoids, immunomodulation
- MeSH terms
- Fluvastatin, Fatty Acids, Monounsaturated, Humans, Hydroxymethylglutaryl CoA Reductases, Indoles, Leukocytes, Mononuclear, Cytokines, Th1 Cells, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Caspase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review